Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients (HepathAlc-IM)
Intestinal Microbiota Profiling in HAA Patients
Sponsor: CH Montdidier
A NA clinical study on Alcohol and Corticosteroids, this trial is actively recruiting participants. The trial is conducted by CH Montdidier and has accumulated 4 data snapshots since 2023. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
First recorded
Nov 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CH Montdidier
- Centre Hospitalier Universitaire, Amiens
For direct contact, visit the study record on ClinicalTrials.gov .